Inhibitors of phosphodiesterase isoforms III or IV suppress islet-cell nitric oxide production.
about
Targeting beta-cell cyclic 3'5' adenosine monophosphate for the development of novel drugs for treating type 2 diabetes mellitus. A review.Postulated vasoactive neuropeptide immunopathology affecting the blood-brain/blood-spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?
P2860
Inhibitors of phosphodiesterase isoforms III or IV suppress islet-cell nitric oxide production.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Inhibitors of phosphodiesteras ...... -cell nitric oxide production.
@en
Inhibitors of phosphodiesteras ...... -cell nitric oxide production.
@nl
type
label
Inhibitors of phosphodiesteras ...... -cell nitric oxide production.
@en
Inhibitors of phosphodiesteras ...... -cell nitric oxide production.
@nl
prefLabel
Inhibitors of phosphodiesteras ...... -cell nitric oxide production.
@en
Inhibitors of phosphodiesteras ...... -cell nitric oxide production.
@nl
P2860
P1476
Inhibitors of phosphodiesteras ...... -cell nitric oxide production.
@en
P2093
Prud'homme GJ
P2860
P2888
P304
P356
10.1038/LABINVEST.3780323
P577
2001-08-01T00:00:00Z